Optimization of left ventricular function with carvedilol before high-risk cardiac surgery

E Kotlyar; P S Macdonald; A M Keogh; R H Arnold; D J McCaffrey; M K Wilson; P M Spratt

doi:10.1016/s1053-2498(01)00303-5

Optimization of left ventricular function with carvedilol before high-risk cardiac surgery

J Heart Lung Transplant. 2001 Oct;20(10):1129-31. doi: 10.1016/s1053-2498(01)00303-5.

Authors

E Kotlyar¹, P S Macdonald, A M Keogh, R H Arnold, D J McCaffrey, M K Wilson, P M Spratt

Affiliation

¹ Cardiopulmonary Transplant Unit, St. Vincent's Hospital, Sydney, New South Wales, Australia.

PMID: 11595569
DOI: 10.1016/s1053-2498(01)00303-5

Abstract

Patients with severe left ventricular dysfunction and symptomatic heart failure caused by ischemic or valvular heart disease face a high morbidity and mortality risk from cardiac surgery. We present data showing that excellent surgical outcome can be achieved after pre-treatment of such patients with carvedilol.

MeSH terms

Adult
Antihypertensive Agents / therapeutic use*
Carbazoles / therapeutic use*
Cardiac Surgical Procedures / methods*
Carvedilol
Female
Humans
Male
Middle Aged
Propanolamines / therapeutic use*
Risk Factors
Treatment Outcome
Vasodilator Agents / therapeutic use
Ventricular Function, Left / drug effects*

Substances

Antihypertensive Agents
Carbazoles
Propanolamines
Vasodilator Agents
Carvedilol